psychosis

Psychosis is a condition that affects a person’s mind and causes changes to the way that they think, feel and behave. A person who experiences psychosis may be unable to distinguish between reality and their imagination. People who are experiencing psychosis are sometimes referred to as psychotic. They may have hallucinations (where you see or hear things that are not there) and/or delusions (where you believe things that are untrue).

Our psychosis Blogs

Continuing antipsychotic medication during pregnancy associated with reduced risk of schizophrenia relapse

A pregnant woman

Shuichi Suetani and Sarah Thomas highlight new research from Korea which suggests that antipsychotic medications do seem to help reduce the relapse of schizophrenia in pregnant women.

[read the full story...]

“Dem sey mi mad”: Afro Caribbean Experiences of Psychosis

Thoughtful,Millennial,African,American,Man,Looking,At,Window,Away,In

Hári Sewell explores Afro Caribbean men’s experiences of psychosis, social and migration difficulties, and challenges accessing mental health services in North America and the United Kingdom.

[read the full story...]

Patterns of inflammation in childhood and mental and cardiometabolic disorders in adulthood: mapping the trajectories

feature

Ruby Tsang summarises a recent longitudinal study of trajectories of inflammation in youth and risk of mental and cardiometabolic disorders in adulthood, which finds that high levels of inflammation in childhood may be linked to an increased risk of psychosis, depression and insulin resistance in early adulthood.

[read the full story...]

HRT associated with reduced risk of psychosis relapse in middle-age women

Close,Up,Head,And,Shoulders,View,Of,Older,Woman,In

Laura Naysmith summarises a study of menopausal hormone therapy (also known as HRT), which suggests the treatment is linked with reduce the risk of psychosis relapse in menopausal women.

[read the full story...]

Omega-3 supplements for the prevention of psychosis: another trial shows no benefit, so is it time to move on?

Feature

David Mongan reports on a recent trial of omega-3 supplementation for the prevention of psychosis in people at ultra-high risk, which finds no evidence of a positive effect. He reflects on these findings and considers what’s next for the field.

[read the full story...]

The role of the gut microbiome in treatment-resistant schizophrenia

Feature

Nuala Murray explores a recent Australian case-control study that looks at the associations between changes in gut microbiota and schizophrenia diagnosis, treatment resistance, and clozapine response.

[read the full story...]

Is short sleep linked to risk of psychosis and could inflammation be a factor?

A sleeping child

Amy Ferguson summarises a recent study published by researchers in Birmingham, which suggests that persistent shorter sleep in childhood may increase the risk of psychotic experiences.

[read the full story...]

KarXT: an innovative and promising treatment for schizophrenia

Hands holding paper head, human brain with flowers, self care and mental health concept, positive thinking, creative mind

Nicola Rizzo Pesci and Andrea Cipriani summarise findings from the EMERGENT-2 trial spotlighting a promising new drug treatment for schizophrenia.

[read the full story...]

Cognition and heterogeneity in first-episode psychosis before antipsychotic treatment

Memory loss and dementia, brain damage concept. Profile of sad man losing parts of his head as symbol of reduced function of brain and mind sitting alone vector illustration

Ana Veic looks at an updated systematic review which suggests that patients with psychosis display cognitive difficulties very early in the disease process, and concludes this variation in cognitive function should prompt individual clinical assessments to optimise care.

[read the full story...]